Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Karimi

Showing results (171-180 of 177) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 177 results.
Vacunas|October 10, 2022
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective studyFazlollah Shokri, Saeed Rezapoor, Masoud Najafi, et al.
Archives of Iranian Medicine|July 11, 2015
A Suggested Prototype for Assessing Bone HealthAbbasali Keshtkar, Patricia Khashayar, Zahra Mohammadi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 13, 2016
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in IranHossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, et al.
Nature Communications|March 8, 2019
Author Correction: Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidatesPhilip Webster, Joanna C Dawes, Hamlata Dewchand, et al.
Nature Communications|July 10, 2018
Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidatesPhilip Webster, Joanna C Dawes, Hamlata Dewchand, et al.
Vaccine: X|November 9, 2023
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trialAkram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
BMC Infectious Diseases|February 24, 2023
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 yearsFatemeh Gholami, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
Pageof 18

Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Vacunas|October 10, 2022
Efficacy of drug regimen with and without oseltamivir in hospitalized patients with COVID-19: A retrospective studyFazlollah Shokri, Saeed Rezapoor, Masoud Najafi, et al.
Archives of Iranian Medicine|July 11, 2015
A Suggested Prototype for Assessing Bone HealthAbbasali Keshtkar, Patricia Khashayar, Zahra Mohammadi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 13, 2016
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in IranHossein Pakdaman, Ali Amini Harandi, Mehdi Abbasi, et al.
Nature Communications|March 8, 2019
Author Correction: Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidatesPhilip Webster, Joanna C Dawes, Hamlata Dewchand, et al.
Nature Communications|July 10, 2018
Subclonal mutation selection in mouse lymphomagenesis identifies known cancer loci and suggests novel candidatesPhilip Webster, Joanna C Dawes, Hamlata Dewchand, et al.
Vaccine: X|November 9, 2023
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trialAkram Ansarifar, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
BMC Infectious Diseases|February 24, 2023
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 yearsFatemeh Gholami, Ramin Hamidi Farahani, Ahmad Karimi Rahjerdi, et al.
Pageof 18